Replies to post #2073 on UniCycive Therapeutics Inc (UNCY)

[rosemountbomber]

Short answer....no.  I guess it depends where you look but I see $47 as avg analyst target (Yahoo finance - I know not a great source) but I definitely think $60 is not out of the question.  I guess I would take some off the table before it got there.  But I could see a scenario where I sell some on a big pop upon approval and then possibly repurchase for the rise based on either sales success or a BO. 

[Stumblebum]

I’ll take $36 per share for my 4600+ that I have but imo once they are established in the 20-40 dollar range a European company will buy them out